Mayo Clinic and Arizona State University officials have been talking about building a biotechnology corridor in north Phoenix since at least 2013, and the project is now closer to fruition. Mayo Clinic was the winning bidder in an Arizona State Land Department public auction, paying $139 million for a 228-acre parcel next to its Phoenix campus on Dec. 15.
The Phoenix metro topped the nation for growth in life sciences employment between 2019 and 2020, according to a new CBRE Group Inc. study, and that employment growth has fueled a need for specialized real estate space that can accommodate lab and research uses.
California-based The City of Hope, which has had an alliance with Phoenix-based Translational Genomics Research Institute for several years, is about to expand its Arizona presence even further. The nonprofit cancer research institute announced Wednesday that it is in talks to pay $390 million to acquire Boca Raton, Florida-based Cancer Treatment Centers of America, a network of oncology hospitals and outpatient care centers, including in metro Phoenix.
A nonprofit genomics research institute created an economic impact of $657.7 million in 2020, more than triple the $199.2 million in 2017, according to a new Tripp Umbach report. The Translational Genomics Research Institute, which was founded in 2002, currently employs 350 people.
The innovation awards and recognition for Arizona-based medical device company SaiOx, Inc. (pronounced SIGH-ox) have been coming fast and furious this fall 2021. The company was selected as 2021 Venture Madness Winner in the medical category by Invest Southwest in partnership with the Arizona Commerce Authority. Venture Madness is Arizona’s longest-running venture capital conference event.
Over the past few decades, Southern Arizona has become a hotspot of bioscience innovation. Through continued collaboration, investments in education and research and a unified bioscience development strategy, our panel of experts asserts that Southern Arizona’s bioscience industry Over the past few decades, Southern Arizona has become a hotspot of bioscience innovation. Through continued collaboration, investments in education and research and a unified bioscience development strategy, our panel of experts asserts that Southern Arizona’s bioscience industry will only continue flourishing.
Amazing things are happening in Downtown Phoenix. The city is experiencing tremendous growth. In addition to welcoming new residents from across the country, Phoenix also has been attracting businesses in the health care and bioscience sector.
The University of Arizona Center for Innovation at Oro Valley is a vital component in the growing innovation ecosystem being developed by The University of Arizona. Establishing a bioscience-focused incubator fills a critical gap and is pivotal in extending the reach of our world-class research and innovation far beyond the university’s campus to benefit society at large.
The University of Arizona Center for Innovation (UACI) is pleased to announce the winning startup of the UACI-sponsored launch competition fueled by the Bioindustry Organization of Southern Arizona (BIOSA). TheraCea Pharma will receive a sponsored year’s admission at the new biotech incubator, UACI at Oro Valley. Included with entrance into the program and space at the new location, the startup will also be awarded a cash prize of $5,000.
Audiologist and molecular biologist O’neil Guthrie, an associate professor in Northern Arizona University’s Department of Communication Sciences and Disorders, is collaborating with New Jersey-based Optigenex to conduct a pre-clinical investigation to help the body’s natural ability to repair DNA through
a novel therapy.